1
40
1
-
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
2020 Oncology List
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Citation List Month
Oncology 2020 List
URL Address
<a href="http://doi.org/10.1080/08880018.2020.1744781" target="_blank" rel="noreferrer noopener">http://doi.org/10.1080/08880018.2020.1744781</a>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Continuous deep sedation at the end of life in children with cancer: experience at a single center in Japan
Publisher
An entity responsible for making the resource available
Pediatric Hematology and Oncology
Date
A point or period of time associated with an event in the lifecycle of the resource
2020
Subject
The topic of the resource
end of life; Palliative sedation; decision-making; ability in daily living; respite sedation
Creator
An entity primarily responsible for making the resource
Maeda S; Kato I; Umeda K; Hiramatsu H; Takita J; Adachi S; Tsuneto S
Description
An account of the resource
Continuous deep sedation (CDS) is used to alleviate unbearable and otherwise refractory symptoms in patients dying of cancer. No data are available concerning CDS in children from Japan to date. This study primarily aimed to describe experience in CDS in child cancer patients at Kyoto University Hospital. The secondary aims were to identify the characteristics of patients who received CDS, and to assess ability in daily living at the end of life. A retrospective chart review was performed for child cancer patients who died at the institute between 2008 and 2017. The data of 35 patients were analyzed. Nine (26%) patients had received CDS. Indications for CDS were dyspnea (56%), agitation (22%), seizures (22%), and pain (11%). Midazolam was used in all nine cases. In eight (89%) patients, opioids were also prescribed. In seven (78%) patients, CDS was performed for < 48 hours. In all nine cases, consent was obtained from the parent(s) but not from the children. CDS was more likely in patients with solid tumors (p = 0.018) and those who had received no respite sedation (p = 0.002). Patients without central nervous system symptoms tended to maintain their capacity for oral intake and verbal communication until a few days prior to death. This is the first report on CDS in child cancer patients from Japan. In the CDS literature, cross-study differences are evident for incidence, target symptoms, duration, and the decision-making process. Further international discussion is warranted concerning indications for CDS and the decision-making process.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1080/08880018.2020.1744781" target="_blank" rel="noreferrer noopener">10.1080/08880018.2020.1744781</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).
2020
ability in daily living
Adachi S
Decision-making
End Of Life
Hiramatsu H
Kato I
Maeda S
Oncology 2020 List
Palliative sedation
Pediatric Hematology And Oncology
respite sedation
Takita J
Tsuneto S
Umeda K